EMA — authorised 21 February 2005
- Marketing authorisation holder: TEVA B.V.
- Status: approved
EMA authorised Azilect on 21 February 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 21 February 2005.
TEVA B.V. holds the EU marketing authorisation.